These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 28007597)

  • 1. Computational proteome-wide screening predicts neurotoxic drug-protein interactome for the investigational analgesic BIA 10-2474.
    Molinski SV; Shahani VM; MacKinnon SS; Morayniss LD; Laforet M; Woollard G; Kurji N; Sanchez CG; Wodak SJ; Windemuth A
    Biochem Biophys Res Commun; 2017 Jan; 483(1):502-508. PubMed ID: 28007597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474.
    van Esbroeck ACM; Janssen APA; Cognetta AB; Ogasawara D; Shpak G; van der Kroeg M; Kantae V; Baggelaar MP; de Vrij FMS; Deng H; Allarà M; Fezza F; Lin Z; van der Wel T; Soethoudt M; Mock ED; den Dulk H; Baak IL; Florea BI; Hendriks G; De Petrocellis L; Overkleeft HS; Hankemeier T; De Zeeuw CI; Di Marzo V; Maccarrone M; Cravatt BF; Kushner SA; van der Stelt M
    Science; 2017 Jun; 356(6342):1084-1087. PubMed ID: 28596366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase.
    Kiss LE; Beliaev A; Ferreira HS; Rosa CP; Bonifácio MJ; Loureiro AI; Pires NM; Palma PN; Soares-da-Silva P
    ChemMedChem; 2018 Oct; 13(20):2177-2188. PubMed ID: 30113139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Portrait of Protein Targets of Metabolites of the Neurotoxic Compound BIA 10-2474.
    Huang Z; Ogasawara D; Seneviratne UI; Cognetta AB; Am Ende CW; Nason DM; Lapham K; Litchfield J; Johnson DS; Cravatt BF
    ACS Chem Biol; 2019 Feb; 14(2):192-197. PubMed ID: 30702848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase.
    Kerbrat A; Ferré JC; Fillatre P; Ronzière T; Vannier S; Carsin-Nicol B; Lavoué S; Vérin M; Gauvrit JY; Le Tulzo Y; Edan G
    N Engl J Med; 2016 Nov; 375(18):1717-1725. PubMed ID: 27806235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bial 10-2474 Phase 1 Study-A Drug Development Perspective and Recommendations for Future First-in-Human Trials.
    Chaikin P
    J Clin Pharmacol; 2017 Jun; 57(6):690-703. PubMed ID: 28387940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral repeated-dose toxicity studies of BIA 10-2474 in beagle dogs.
    Hardisty JF; Harris SB; Hayes WA; Weber K
    Regul Toxicol Pharmacol; 2020 Mar; 111():104555. PubMed ID: 31874201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on BIA 10-2474.
    Hayes AW
    Regul Toxicol Pharmacol; 2020 Mar; 111():104541. PubMed ID: 31759139
    [No Abstract]   [Full Text] [Related]  

  • 9. Lessons from the fatal French study BIA-10-2474.
    Moore N
    BMJ; 2016 May; 353():i2727. PubMed ID: 27193592
    [No Abstract]   [Full Text] [Related]  

  • 10. Statistical issues in first-in-human studies on BIA 10-2474: Neglected comparison of protocol against practice.
    Bird SM; Bailey RA; Grieve AP; Senn S
    Pharm Stat; 2017 Mar; 16(2):100-106. PubMed ID: 28206702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, SAR study, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase (FAAH) inhibitors.
    Kono M; Matsumoto T; Kawamura T; Nishimura A; Kiyota Y; Oki H; Miyazaki J; Igaki S; Behnke CA; Shimojo M; Kori M
    Bioorg Med Chem; 2013 Jan; 21(1):28-41. PubMed ID: 23218778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the BIA-102474-101 study for review of first-into-human clinical trials.
    Eddleston M; Cohen AF; Webb DJ
    Br J Clin Pharmacol; 2016 Apr; 81(4):582-6. PubMed ID: 26996741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-clinical toxicology evaluation of BIA 10-2474.
    Hayes AW; Weber K; Moser P; Soares-da-Silva P
    Crit Rev Toxicol; 2021 Jan; 51(1):65-75. PubMed ID: 33528291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open letter on access to the BIA 10-2474 clinical trial data.
    Brøsen K; Funck-Brentano C; Kroemer HK; Pirmohamed M; Schwab M
    Lancet; 2017 Jan; 389(10065):156. PubMed ID: 27955829
    [No Abstract]   [Full Text] [Related]  

  • 15. 1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase.
    Keith JM; Hawryluk N; Apodaca RL; Chambers A; Pierce JM; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Scott BP; Wilson SJ; Luo L; Wennerholm ML; Chang L; Rizzolio M; Chaplan SR; Breitenbucher JG
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1280-4. PubMed ID: 24513048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Take Care of the Fast-in-Human Study.
    van Hoogdalem EJ
    Clin Transl Sci; 2017 May; 10(3):122-123. PubMed ID: 27981812
    [No Abstract]   [Full Text] [Related]  

  • 17. Global identification of O-GlcNAc transferase (OGT) interactors by a human proteome microarray and the construction of an OGT interactome.
    Deng RP; He X; Guo SJ; Liu WF; Tao Y; Tao SC
    Proteomics; 2014 May; 14(9):1020-30. PubMed ID: 24536041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia.
    Wu W; Li Z; Yang G; Teng M; Qin J; Hu Z; Hou L; Shen L; Dong H; Zhang Y; Li J; Chen S; Tian J; Zhang J; Ye L
    Bioorg Med Chem Lett; 2017 May; 27(10):2210-2215. PubMed ID: 28385504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of SRC as a potent drug target for asthma, using an integrative approach of protein interactome analysis and in silico drug discovery.
    Randhawa V; Bagler G
    OMICS; 2012 Oct; 16(10):513-26. PubMed ID: 22775150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms involved in the side effects of fatty acid amide hydrolase inhibitors: a structural phenomics approach to proteome-wide cellular off-target deconvolution and disease association.
    Dider S; Ji J; Zhao Z; Xie L
    NPJ Syst Biol Appl; 2016; 2():16023. PubMed ID: 28725477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.